ATE230025T1 - Proteinanaloge des ldl-rezeptors und deren kodierende gene - Google Patents

Proteinanaloge des ldl-rezeptors und deren kodierende gene

Info

Publication number
ATE230025T1
ATE230025T1 AT96116108T AT96116108T ATE230025T1 AT E230025 T1 ATE230025 T1 AT E230025T1 AT 96116108 T AT96116108 T AT 96116108T AT 96116108 T AT96116108 T AT 96116108T AT E230025 T1 ATE230025 T1 AT E230025T1
Authority
AT
Austria
Prior art keywords
ldl receptor
sequence
encoding genes
protein analogues
dna
Prior art date
Application number
AT96116108T
Other languages
English (en)
Inventor
Yasushi Saito
Akio Iwasaki
Koichi Arai
Hiroyuki Yamazaki
Original Assignee
Kowa Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kowa Co filed Critical Kowa Co
Application granted granted Critical
Publication of ATE230025T1 publication Critical patent/ATE230025T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT96116108T 1995-10-09 1996-10-08 Proteinanaloge des ldl-rezeptors und deren kodierende gene ATE230025T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP26144095 1995-10-09
JP8102451A JPH09163988A (ja) 1995-10-09 1996-04-24 新規なｌｄｌ受容体類似蛋白質及び遺伝子

Publications (1)

Publication Number Publication Date
ATE230025T1 true ATE230025T1 (de) 2003-01-15

Family

ID=26443171

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96116108T ATE230025T1 (de) 1995-10-09 1996-10-08 Proteinanaloge des ldl-rezeptors und deren kodierende gene

Country Status (8)

Country Link
US (1) US5665872A (de)
EP (1) EP0773290B1 (de)
JP (1) JPH09163988A (de)
AT (1) ATE230025T1 (de)
DE (1) DE69625448T2 (de)
DK (1) DK0773290T3 (de)
ES (1) ES2191728T3 (de)
PT (1) PT773290E (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996017058A1 (en) * 1994-11-30 1996-06-06 Nippon Chemiphar Co., Ltd. Denatured low-density lipoprotein receptor
EP0969855B1 (de) * 1996-11-27 2006-02-08 Boston Heart Foundation, Inc. Neue low density lipoprotein bindende proteine und deren verwendung in der diagnostik und behandlung von atherosklerose
US6632923B1 (en) * 1996-11-27 2003-10-14 Boston Heart Foundation, Inc. Low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis
US6605588B1 (en) 1996-11-27 2003-08-12 Boston Heart Foundation, Inc. Low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis
US6962989B1 (en) * 1999-07-08 2005-11-08 Basf Aktiengesellschaft Corynebacterium glutamicum genes encoding novel proteins
DE10037759A1 (de) * 2000-08-03 2002-07-04 Gruenenthal Gmbh Screeningverfahren
US20110177610A1 (en) * 2007-06-18 2011-07-21 Sekisui Medical Co., Ltd. Novel marker for arteriosclerotic disease
JP4459299B2 (ja) 2008-03-21 2010-04-28 積水メディカル株式会社 可溶性ｌｒ１１の定量方法
CN102656456B (zh) 2009-12-16 2015-04-08 积水医疗株式会社 恶性肿瘤的诊断方法
WO2012008594A1 (ja) 2010-07-15 2012-01-19 積水メディカル株式会社 悪性腫瘍細胞の検出方法
KR101894417B1 (ko) 2011-05-09 2018-09-03 세키스이 메디칼 가부시키가이샤 가용성 lr11의 면역학적 측정방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0586094A1 (de) * 1992-08-03 1994-03-09 Wisconsin Alumni Research Foundation Löslicher LDL-Rezeptor und Gen
AU5457294A (en) * 1992-10-29 1994-05-24 Board Of Regents, The University Of Texas System Adenovirus-mediated ldl receptor gene transfer and targeting
US5750367A (en) * 1993-11-08 1998-05-12 Baylor College Of Medicine Human and mouse very low density lipoprotein receptors and methods for use of such receptors

Also Published As

Publication number Publication date
EP0773290A2 (de) 1997-05-14
EP0773290B1 (de) 2002-12-18
ES2191728T3 (es) 2003-09-16
EP0773290A3 (de) 1998-07-08
PT773290E (pt) 2003-04-30
JPH09163988A (ja) 1997-06-24
DE69625448T2 (de) 2003-05-15
US5665872A (en) 1997-09-09
DE69625448D1 (de) 2003-01-30
DK0773290T3 (da) 2003-01-13

Similar Documents

Publication Publication Date Title
BR9814276A (pt) Antìgenos de superfìcie
EP1439230A3 (de) Menschliche transmembranprotein TMP-2 gen
PL331005A1 (en) Regulating dna of hamster's ef-1alpha transcription
ATE540111T1 (de) Hla-dr-bindendes antigenpeptid, das von wt1 abgeleitet ist
CY1111950T1 (el) 32 ανθρωπινες εκκρινομενες πρωτεϊνες
DE69839014D1 (de) Apolipoprotein a-i agonisten und deren verwendung zur behandlung dyslipidämischer erkrankungen
ATE323510T1 (de) Gentherapeutische verfahren zur bereitstellung von apolipoprotein a-i agonisten sowie deren verwendung zur behandlung dyslipidämischer erkrankungen
ATE230025T1 (de) Proteinanaloge des ldl-rezeptors und deren kodierende gene
BR9710665A (pt) Compostos que promovem o desenvolvimento do tecido
EP1310554A4 (de) DEN PHOSPHORSÄURE-METABOLISMUS KONTROLLIERENDE POLYPEPTIDE, KALZIUM-METABOLISMUS, VERKALKUNG UND VITAMIN D-METABOLISMUS UND FüR DIESE KODIERENDE DNA-MOLEKÜLE
EP0947583A3 (de) Expressionsaktivierende Nukleinsäurefragmente des Melanom-inhibierenden Proteins (MIA)
EP1037999A4 (de) Porphorymonas gingivalis polypeptide und polynukleotide
AUPN154295A0 (en) Nucleic acid molecule encoding a protein with avian gamma-interferon activity
WO2000023587A3 (en) Gene therapy of alzheimer's disease by delivery of an encoded apolipoprotein e
DE59410423D1 (de) Serin-threonin-kinase enthaltendes mittel zur tumortherapie und tumordiagnose
EP0919621A4 (de) Menschliche tak1 und für diese kodierende dna
ZA982009B (en) Isolated nucleic acid molecules encoding SSX family members and uses thereof.
EP0870036A4 (de) Synthetische säugetier alpha-n-aectylglukosaminidase und dafür kodierende genetische sequenzen
BR9510323A (pt) Variante de dnase i humana ácido nucleico isolado método para tratamento de um paciente tendo uma desordem ou doença pulmonar e composição farmacêutica
ES2099304T3 (es) Mitogeno de la musculatura lisa y adn que lo codifica.
DE69839701D1 (de) Neues gen, welches bei der krankheit apeced defekt ist, und dessen verwendungen
AU2002350406A1 (en) Identification of ses-3 (spr-5) in c. elegans and the uses of the same
AU2002314193A1 (en) Identification of ses-1 and the uses of the same
ATE198218T1 (de) Htfiiia gen
DK0754754T3 (da) Gen for FK506 bindende protein

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0773290

Country of ref document: EP

REN Ceased due to non-payment of the annual fee